Cardiff Oncology
CRDF
CRDF
117 hedge funds and large institutions have $122M invested in Cardiff Oncology in 2024 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 40 increasing their positions, 16 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
41% more funds holding
Funds holding: 83 → 117 (+34)
14.82% more ownership
Funds ownership: 27.41% → 42.23% (+15%)
Holders
117
Holding in Top 10
–
Calls
$4.64M
Puts
$1.32M
Top Buyers
| 1 | +$23.4M | |
| 2 | +$6.68M | |
| 3 | +$5.61M | |
| 4 |
LCM
Laurion Capital Management
New York
|
+$2.5M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$2.21M |
Top Sellers
| 1 | -$1.37M | |
| 2 | -$882K | |
| 3 | -$676K | |
| 4 |
Renaissance Technologies
New York
|
-$518K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$349K |